About

Dr. Gary Tozbikian is a surgical oncologist whose research centers on advancing breast cancer surgery, particularly through minimally invasive techniques and improved oncologic outcomes. His most cited work investigates residual breast tissue after robot-assisted nipple-sparing mastectomy (RNSM), a critical surrogate marker for the procedure’s oncologic safety. This 2020 study, with 20 citations, provides foundational evidence that RNSM may leave behind breast tissue, raising important questions about long-term recurrence risks and guiding refinements in surgical practice. Dr. Tozbikian’s contributions help bridge the gap between innovative robotic approaches and rigorous oncologic principles, directly impacting how surgeons evaluate and perform mastectomies. His research is instrumental for clinicians and researchers focused on optimizing breast cancer surgery, balancing cosmetic benefits with safety. By quantifying residual tissue, his work supports evidence-based decision-making in an evolving field, marking him as a key voice in the ongoing dialogue about robotic mastectomy’s role in comprehensive breast cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Residual breast tissue after robot-assisted nipple sparing mastectomy
20 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago